INTERIM REPORT OF BIOHIT GROUP 1 JANUARY TO 30 JUNE 2007
The Biohit Group had total net sales of EUR 16.1 million during the reportingperiod (EUR 15.2 million in 1Q-2Q/2006). The operating loss for the reportingperiod was EUR 0.7 million (operating loss EUR 0.3 million). The loss for theperiod was EUR 0.8 million (loss EUR 0.6 million). The result was weakened byslower than expected sales development for liquid handling and diagnosticproducts in the Asian markets. NET SALES The Biohit Group's net sales rose by 6 % compared with the corresponding periodin 2006 and totalled EUR 16.1 million (EUR 15.2 million). Sales of liquidhandling